Skip to main content
# Title Department Research Member Research Year
21 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2024
22 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024
23 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2024
24 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2023
25 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023
26 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
27 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023
28 Efficacy of pectoralis plane block versus wound instillation using ketamine with bupivacaine on postoperative analgesia following modified radical mastectomy, a randomized study Department of Anesthesia, Intensive care and Pain management Dr. Ahmad Mohammad Abd El-Rahman 2023
29 Surgical Outcomes of Laparoscopic-assisted Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy Billroth I for Gastric Cancer Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
30 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Department of Medical Oncology Sanaa Saber Abdelraheem Barakat 2023